55 related articles for article (PubMed ID: 10639006)
1. Biphasic response to lipopolysaccharide from E. coli in the isolated ventilated blood-perfused rat lung.
Chlopicki S; Bartuś JB; Gryglewski RJ
J Physiol Pharmacol; 1999 Dec; 50(4):551-65. PubMed ID: 10639006
[TBL] [Abstract][Full Text] [Related]
2. Role of thromboxane A2 and platelet activating factor in early haemodynamic response to lipopolysaccharide in rats.
Bocheński J; Chłopicki S; Gryglewski RJ
J Physiol Pharmacol; 1999 Jun; 50(2):287-97. PubMed ID: 10424723
[TBL] [Abstract][Full Text] [Related]
3. Involvement of platelet activating factor in immediate heart response to lipopolysaccharide.
Jakubowski A; Olszanecki R; Chlopicki S
J Physiol Pharmacol; 2004 Jun; 55(2):409-21. PubMed ID: 15213362
[TBL] [Abstract][Full Text] [Related]
4. Endotoxaemia in rats: role of NO, PAF and TXA2 in pulmonary neutrophil sequestration and hyperlactataemia.
Olszanecki R; Chłopicki S
J Physiol Pharmacol; 1999 Sep; 50(3):443-54. PubMed ID: 10574473
[TBL] [Abstract][Full Text] [Related]
5. Increased pneumotoxicity of lipopolysaccharide from E.coli in nitric oxide deficient blood-perfused rat lungs.
Bartuś JB; Chłopicki S; Gryglewski RJ
J Physiol Pharmacol; 1997 Dec; 48(4):655-63. PubMed ID: 9444614
[TBL] [Abstract][Full Text] [Related]
6. Hypoxic pulmonary vasoconstriction in isolated blood-perfused rat lung; modulation by thromboxane A2, platelet-activating factor, cysteinyl leukotrienes and endothelin-1.
Chłopicki S; Bartuś JB; Gryglewski RJ
Pol J Pharmacol; 2002; 54(5):433-41. PubMed ID: 12593530
[TBL] [Abstract][Full Text] [Related]
7. Platelet-activating factor and bacteremia-induced pulmonary hypertension.
Clavijo LC; Carter MB; Matheson PJ; Wills-Frank LA; Wilson MA; Wead WB; Garrison RN
J Surg Res; 2000 Feb; 88(2):173-80. PubMed ID: 10644485
[TBL] [Abstract][Full Text] [Related]
8. A study of mechanisms underlying amitriptyline-induced acute lung function impairment.
Svens K; Ryrfeldt A
Toxicol Appl Pharmacol; 2001 Dec; 177(3):179-87. PubMed ID: 11749117
[TBL] [Abstract][Full Text] [Related]
9. Effects of platelet-activating factor, thromboxane A2 and leukotriene D4 on isolated perfused rat liver.
Cui S; Shibamoto T; Liu W; Takano H; Kurata Y
Prostaglandins Other Lipid Mediat; 2006 Jul; 80(1-2):35-45. PubMed ID: 16846785
[TBL] [Abstract][Full Text] [Related]
10. Hyperosmolar solution effects in guinea pig airways. IV. Lipopolysaccharide-induced alterations in airway reactivity and epithelial bioelectric responses to methacholine and hyperosmolarity.
Johnston RA; Van Scott MR; Kommineni C; Millecchia LL; Dortch-Carnes J; Fedan JS
J Pharmacol Exp Ther; 2004 Jan; 308(1):37-46. PubMed ID: 14566002
[TBL] [Abstract][Full Text] [Related]
11. Residual pulmonary neutrophils are involved in vaso- and bronchoconstrictor responses to platelet activating factor in the isolated buffer-perfused rat lung.
Chłopicki S; Olszanecki R; Jawień J; Bartuś JB; Gryglewski RJ
Pol J Pharmacol; 2000; 52(3):217-22. PubMed ID: 11055579
[TBL] [Abstract][Full Text] [Related]
12. Roles of thromboxane A2 and 5-hydroxytryptamine in endotoxin-induced digital vasoconstriction in horses.
Menzies-Gow NJ; Sepulveda MF; Bailey SR; Cunningham FM; Elliott J
Am J Vet Res; 2008 Feb; 69(2):199-207. PubMed ID: 18241016
[TBL] [Abstract][Full Text] [Related]
13. Role of platelet-activating factor in pneumolysin-induced acute lung injury.
Witzenrath M; Gutbier B; Owen JS; Schmeck B; Mitchell TJ; Mayer K; Thomas MJ; Ishii S; Rosseau S; Suttorp N; Schütte H
Crit Care Med; 2007 Jul; 35(7):1756-62. PubMed ID: 17522574
[TBL] [Abstract][Full Text] [Related]
14. Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model.
Silliman CC; Voelkel NF; Allard JD; Elzi DJ; Tuder RM; Johnson JL; Ambruso DR
J Clin Invest; 1998 Apr; 101(7):1458-67. PubMed ID: 9525989
[TBL] [Abstract][Full Text] [Related]
15. Staphylococcus aureus alpha-toxin and Escherichia coli hemolysin impair cardiac regional perfusion and contractile function by activating myocardial eicosanoid metabolism in isolated rat hearts.
Grandel U; Bennemann U; Buerke M; Hattar K; Seeger W; Grimminger F; Sibelius U
Crit Care Med; 2009 Jun; 37(6):2025-32. PubMed ID: 19384217
[TBL] [Abstract][Full Text] [Related]
16. Platelet shape change in whole blood: differential effects of endotoxin.
Nystrom ML; Barradas MA; Jeremy JY; Mikhailidis DP
Thromb Haemost; 1994 May; 71(5):646-50. PubMed ID: 8091394
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide-dependent reduction in soluble guanylate cyclase functionality accounts for early lipopolysaccharide-induced changes in vascular reactivity.
Fernandes D; da Silva-Santos JE; Duma D; Villela CG; Barja-Fidalgo C; Assreuy J
Mol Pharmacol; 2006 Mar; 69(3):983-90. PubMed ID: 16326931
[TBL] [Abstract][Full Text] [Related]
18. The effect of tumor necrosis factor-alpha on microvascular permeability in an isolated, perfused lung.
Schulman CI; Wright JK; Nwariaku F; Sarosi G; Turnage RH
Shock; 2002 Jul; 18(1):75-81. PubMed ID: 12095138
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo pharmacological characterization of BM-613 [N-n-pentyl-N'-[2-(4'-methylphenylamino)-5-nitrobenzenesulfonyl]urea], a novel dual thromboxane synthase inhibitor and thromboxane receptor antagonist.
Hanson J; Rolin S; Reynaud D; Qiao N; Kelley LP; Reid HM; Valentin F; Tippins J; Kinsella BT; Masereel B; Pace-Asciak C; Pirotte B; Dogné JM
J Pharmacol Exp Ther; 2005 Apr; 313(1):293-301. PubMed ID: 15626721
[TBL] [Abstract][Full Text] [Related]
20. Role of poly-(ADP-ribose) synthetase in lipopolysaccharide-induced vascular failure and acute lung injury in pigs.
Albertini M; Clement MG; Lafortuna CL; Caniatti M; Magder S; Abdulmalek K; Hussain SN
J Crit Care; 2000 Jun; 15(2):73-83. PubMed ID: 10877368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
